Literature DB >> 22515449

Inactivation of X-linked tumor suppressor genes in human cancer.

Runhua Liu1, Mandy Kain, Lizhong Wang.   

Abstract

Cancer cells silence autosomal tumor suppressor genes by Knudson's two-hit mechanism in which loss-of-function mutations and then loss of heterozygosity occur at the tumor suppressor gene loci. However, the identification of X-linked tumor suppressor genes has challenged the traditional theory of 'two-hit inactivation' in tumor suppressor genes, introducing the novel concept that a single genetic hit can cause loss of tumor suppressor function. The mechanism through which these genes are silenced in human cancer is unclear, but elucidating the details will greatly enhance our understanding of the pathogenesis of human cancer. Here, we review the identification of X-linked tumor suppressor genes and discuss the potential mechanisms of their inactivation. In addition, we also discuss how the identification of X-linked tumor suppressor genes can potentially lead to new approaches in cancer therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22515449      PMCID: PMC4369797          DOI: 10.2217/fon.12.26

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  216 in total

1.  The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells.

Authors:  H Daniel Lacorazza; Yasushi Miyazaki; Antonio Di Cristofano; Anthony Deblasio; Cyrus Hedvat; Jin Zhang; Carlos Cordon-Cardo; Shifeng Mao; Pier Paolo Pandolfi; Stephen D Nimer
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

2.  The QM gene is X-linked and therefore not involved in suppression of tumorigenesis in Wilms' tumor.

Authors:  A M van den Ouweland; M Verdijk; M M Mannens; B A van Oost
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

3.  P53 is a tumor suppressor gene.

Authors:  Arnold J Levine; Cathy A Finlay; Philip W Hinds
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

4.  Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.

Authors:  Yan Guo; Fei Yuan; Huan Deng; Hua-Feng Wang; Xiao-Long Jin; Jia-Cheng Xiao
Journal:  Am J Surg Pathol       Date:  2011-06       Impact factor: 6.394

5.  LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients.

Authors:  Hatice Duzkale; Carmen D Schweighofer; Kevin R Coombes; Lynn L Barron; Alessandra Ferrajoli; Susan O'Brien; William G Wierda; John Pfeifer; Tadeusz Majewski; Bogdan A Czerniak; Jeffrey L Jorgensen; L Jeffrey Medeiros; Emil J Freireich; Michael J Keating; Lynne V Abruzzo
Journal:  Blood       Date:  2011-02-10       Impact factor: 22.113

6.  Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas.

Authors:  Cinzia Azzoni; Lorena Bottarelli; Silvia Pizzi; Tiziana D'Adda; Guido Rindi; Cesare Bordi
Journal:  Virchows Arch       Date:  2005-10-22       Impact factor: 4.064

7.  A comprehensive catalogue of somatic mutations from a human cancer genome.

Authors:  Erin D Pleasance; R Keira Cheetham; Philip J Stephens; David J McBride; Sean J Humphray; Chris D Greenman; Ignacio Varela; Meng-Lay Lin; Gonzalo R Ordóñez; Graham R Bignell; Kai Ye; Julie Alipaz; Markus J Bauer; David Beare; Adam Butler; Richard J Carter; Lina Chen; Anthony J Cox; Sarah Edkins; Paula I Kokko-Gonzales; Niall A Gormley; Russell J Grocock; Christian D Haudenschild; Matthew M Hims; Terena James; Mingming Jia; Zoya Kingsbury; Catherine Leroy; John Marshall; Andrew Menzies; Laura J Mudie; Zemin Ning; Tom Royce; Ole B Schulz-Trieglaff; Anastassia Spiridou; Lucy A Stebbings; Lukasz Szajkowski; Jon Teague; David Williamson; Lynda Chin; Mark T Ross; Peter J Campbell; David R Bentley; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

8.  Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.

Authors:  M K Dodson; L C Hartmann; W A Cliby; K A DeLacey; G L Keeney; S R Ritland; J Q Su; K C Podratz; R B Jenkins
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

View more
  13 in total

1.  IPEX Syndrome, FOXP3 and Cancer.

Authors:  Runhua Liu; Silin Li; Wei-Hsiung Yang; Lizhong Wang
Journal:  J Syndr       Date:  2013-06

2.  FOXP3-miR-146-NF-κB Axis and Therapy for Precancerous Lesions in Prostate.

Authors:  Runhua Liu; Bin Yi; Shi Wei; Wei-Hsiung Yang; Karen M Hart; Priyanka Chauhan; Wei Zhang; Xicheng Mao; Xiuping Liu; Chang-Gong Liu; Lizhong Wang
Journal:  Cancer Res       Date:  2015-02-23       Impact factor: 12.701

Review 3.  Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View.

Authors:  Sadegh Rajabi; Catherine Alix-Panabières; Arshia Sharbatdar Alaei; Raziyeh Abooshahab; Heewa Shakib; Mohammad Reza Ashrafi
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

Review 4.  Deciphering the Role of the Barr Body in Malignancy: An insight into head and neck cancer.

Authors:  Deepti Sharma; George Koshy; Shruti Gupta; Bhushan Sharma; Sonal Grover
Journal:  Sultan Qaboos Univ Med J       Date:  2018-01-10

5.  Overexpression of the transcription factor FOXP3 in lung adenocarcinoma sustains malignant character by promoting G1/S transition gene CCND1.

Authors:  Yinan Li; Dong Li; Wei Yang; Haiying Fu; Yaqing Liu; Yi Li
Journal:  Tumour Biol       Date:  2015-12-16

6.  Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.

Authors:  Victoria Stepanova; Konstantin V Dergilev; Kelci R Holman; Yelena V Parfyonova; Zoya I Tsokolaeva; Mimi Teter; Elena N Atochina-Vasserman; Alla Volgina; Sergei V Zaitsev; Shane P Lewis; Fedor G Zabozlaev; Kseniya Obraztsova; Vera P Krymskaya; Douglas B Cines
Journal:  J Biol Chem       Date:  2017-09-27       Impact factor: 5.157

7.  Forkhead box P3 regulates ARHGAP15 expression and affects migration of glioma cells through the Rac1 signaling pathway.

Authors:  Zhen Sun; Biao Zhang; Chen Wang; Tao Fu; Lianling Li; Qiaoli Wu; Ying Cai; Jinhuan Wang
Journal:  Cancer Sci       Date:  2017-01-23       Impact factor: 6.716

8.  Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST.

Authors:  Hsiang-Chih Lu; Vanessa Eulo; Anthony J Apicelli; Melike Pekmezci; Yu Tao; Jingqin Luo; Angela C Hirbe; Sonika Dahiya
Journal:  Oncotarget       Date:  2018-05-01

9.  The X-linked tumor suppressor TSPX downregulates cancer-drivers/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner.

Authors:  Tatsuo Kido; Yunmin Li; Yuichiro Tanaka; Rajvir Dahiya; Yun-Fai Chris Lau
Journal:  Oncotarget       Date:  2019-02-19

10.  Progress in the correlation between PTPN12 gene expression and human tumors.

Authors:  Yu-Hu Huo; Ya-Ni Wang; Ling-Bing Meng; Ai-Li Zhang; Bin Liu
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.